Held under the theme "Cooperation for Lung Health," the congress brought together 103 speakers from 12 countries, featuring nearly 160 scientific presentations covering the latest developments in respiratory medicine, pulmonary intervention, and related specialties.
As a sponsor, HDN Investment Joint Stock Company, in collaboration with ForTsing Medical (Hong Kong), showcased an interactive technology exhibition under the theme "Optimizing Access, Diagnosis, and Intervention for Peripheral Pulmonary Nodules." The exhibition featured an integrated portfolio of advanced medical technologies designed to support the entire clinical pathway from robotic bronchoscopy systems and bronchoscopy training simulators to a comprehensive range of interventional consumables.
Highlights from HDN at VNRS 2026:
At the exhibition booth, HDN introduced its AI-assisted bronchoscopy solutions, including the Polaris Robotic Bronchoscopy System, bronchoscopy simulation and training platforms, and a portfolio of interventional devices such as airway stents, lesion localization needles, and transbronchial biopsy needles. These technologies are designed to support minimally invasive diagnosis and intervention for pulmonary diseases while enhancing procedural precision and clinical workflow efficiency.
The robotic bronchoscopy platform was also featured during the pre-congress educational program by Associate Professor Terence Tam Chi Chun of The University of Hong Kong, an internationally recognized expert in ultrathin bronchoscopy and advanced peripheral airway access. The hands-on training session attracted physicians and specialists from across Vietnam, providing participants with opportunities to practice procedural techniques using dedicated simulation models.
Throughout the exhibition, HDN's bronchoscopy solutions facilitated extensive scientific exchange among clinicians and industry specialists, with participants sharing valuable clinical perspectives and technical feedback on emerging technologies for minimally invasive pulmonary intervention.
Related article: AI-Powered Pulmonary Intervention Technology launched at a Scientific Workshop with Leading International Experts
As the official distributor of ForTsing Medical in Vietnam, HDN Investment Joint Stock Company remains committed to introducing innovative technologies for airway intervention and minimally invasive pulmonary procedures. We sincerely thank all physicians, healthcare professionals, and delegates who visited our booth and participated in the scientific discussions throughout VNRS 2026.
